Practical instructions for using drugs in CT and MR cardiac imaging

Giuseppe Rovere, Agostino Meduri, Giancarlo Savino, Francesco Ciriaco Flammia, Francesca Lo Piccolo, Maria Rachele Pia Carafa, Anna Rita Larici, Luigi Natale, Biagio Merlino, Riccardo Marano

Risultato della ricerca: Contributo in rivistaArticolo in rivistapeer review


The progressive increase in numbers of noninvasive cardiac imaging examinations broadens the spectrum of knowledge radiologists are expected to acquire in the management of drugs during CT coronary angiography (CTCA) and cardiac MR (CMR) to improve image quality for optimal visualization and assessment of the coronary arteries and adequate MR functional analysis. Aim of this review is to provide an overview on different class of drugs (nitrate, beta-blockers, ivabradine, anxiolytic, adenosine, dobutamine, atropine, dipyridamole and regadenoson) that can be used in CTCA and CMR, illustrating their main indications, contraindications, efficacy, mechanism of action, metabolism, safety, side effects or complications, and providing advices in their use.
Lingua originaleEnglish
pagine (da-a)356-364
Numero di pagine9
Stato di pubblicazionePubblicato - 2021


  • Adenosine
  • Adrenergic beta-Antagonists
  • Anti-Anxiety Agents
  • Atropine
  • Calcium Channel Blockers
  • Cardiac Imaging Techniques
  • Computed Tomography Angiography
  • Contraindications
  • Contraindications, Drug
  • Coronary Angiography
  • Coronary Vessels
  • Dipyridamole
  • Dobutamine
  • Heart
  • Humans
  • Ivabradine
  • Magnetic Resonance Imaging
  • Nitroglycerin
  • Purines
  • Pyrazoles
  • Regadenoson
  • Vasodilator Agents


Entra nei temi di ricerca di 'Practical instructions for using drugs in CT and MR cardiac imaging'. Insieme formano una fingerprint unica.

Cita questo